Stocks
Scinai Immunotherapeutics Ltd.SCNI
NASDAQHealthcareBiotechnology$0.73
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing immunotherapies for autoimmune and inflammatory diseases, with a lead product candidate targeting IL-17 pathways. Its pipeline includes both in-house programs and a partnership with a larger pharma, and investors track it for its potential in the psoriasis and psoriatic arthritis markets. The company also operates a contract development and manufacturing organization (CDMO) segment to generate near-term revenue.
52W Range: $0.66-$15.50
Congressional Interest in Scinai Immunotherapeutics Ltd. (SCNI)
No congressional trades have been disclosed for Scinai Immunotherapeutics Ltd. (SCNI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SCNI?
No congressional trades found for this stock.